financetom
Business
financetom
/
Business
/
Arcos Dorados Offers to Buy Back Outstanding 5.875% Notes Due 2027
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arcos Dorados Offers to Buy Back Outstanding 5.875% Notes Due 2027
Jan 15, 2025 8:10 AM

10:55 AM EST, 01/15/2025 (MT Newswires) -- Arcos Dorados ( ARCO ) said Wednesday it started an offer to buy for cash all of its outstanding 5.875% notes due 2027.

The outstanding principal amount on the notes is about $386 million, the company said. The the notes will be purchased for a consideration of $1,000 per outstanding principal amount along with accrued and unpaid interest, the company said.

The tender offer expires on Jan. 23 and is in connection with a potential offering of senior notes issued by an Arcos unit, the company added.

Shares of Arcos were up 1% in recent trading.

Price: 7.47, Change: +0.10, Percent Change: +1.36

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Shift4 Payments Launches Global Cryptocurrency Payment Service
Shift4 Payments Launches Global Cryptocurrency Payment Service
Nov 3, 2024
09:42 AM EDT, 10/28/2024 (MT Newswires) -- Shift4 Payments ( FOUR ) said Monday it has launched Pay with Crypto, allowing businesses worldwide to accept cryptocurrency for e-commerce and point-of-sale transactions. The service supports various cryptocurrencies, including Bitcoin, Ethereum, Solana, and US Dollar Coin, and payments will be automatically converted to US dollars for settlement, Shift4 said. The new feature,...
Organon Finalizes Acquisition of Dermavant From Roivant
Organon Finalizes Acquisition of Dermavant From Roivant
Nov 3, 2024
09:44 AM EDT, 10/28/2024 (MT Newswires) -- Organon (OGN) said Monday it finalized the acquisition of Dermavant Sciences from Roivant (ROIV). Dermavant develops and commercializes treatments in the immuno-dermatology space, including Vtama, which was approved by the US Food and Drug Administration to treat plaque psoriasis in adults, Organon said. Price: 17.37, Change: +0.21, Percent Change: +1.22 ...
Ironwood Says Apraglutide Shows 'Consistent Treatment Effect' in Short Bowel Syndrome; Shares Rise
Ironwood Says Apraglutide Shows 'Consistent Treatment Effect' in Short Bowel Syndrome; Shares Rise
Nov 3, 2024
09:42 AM EDT, 10/28/2024 (MT Newswires) -- Ironwood Pharmaceuticals ( IRWD ) said Monday that data from a phase 3 trial assessing apraglutide in adults with short bowel syndrome with intestinal failure showed a consistent treatment effect. The consistent effect was seen across subgroups: gender, age, body weight, region, race, ethnicity and [short bowel syndrome characteristics] -- including length of...
First Northwest Bancorp Says FDIC Terminates Consent Order Against Unit
First Northwest Bancorp Says FDIC Terminates Consent Order Against Unit
Nov 3, 2024
09:43 AM EDT, 10/28/2024 (MT Newswires) -- First Northwest Bancorp's ( FNWB ) First Fed Bank unit said Monday the Federal Deposit Insurance Corp. has terminated the November 2023 consent order issued against the bank. First Fed Bank said it has resolved the deficiencies in its compliance program that was the subject of the FDIC's order. In other news, First...
Copyright 2023-2026 - www.financetom.com All Rights Reserved